Efficacy of acupoint catgut embedding therapy for phlegm-turbidity and blood-stasis metabolic dysfunction-associated fatty liver disease

Table 4 Total cholesterol, triglyceride, alanine aminotransferase, and aspartate aminotransferase comparisons

		TC (mmol/L)	TG (mmol/L)	ALT (U/L)	AST (U/L)
ACET group	Before treatment	4.86 ± 0.99	3.41 ± 1.72	130.09 ± 54.31	44.28 ± 43.95
	After treatment	4.27 ± 0.76a	2.19 ± 0.73a	39.62 ± 17.58a	36.86 ± 47.30a
Control group	Before treatment	4.73 ± 0.47	3.30 ± 1.65	121.70 ± 60.3	51.26 ± 38.73
	After treatment	4.61 ± 0.52b	3.04 ± 1.12b	69.56 ± 33.83b	46.86 ± 49.69b

^aP < 0.05, pre- vs post-treatment in the acupoint catgut embedding therapy (ACET) group.

^bP < 0.05, ACET vs control post-treatment.

TC: Total cholesterol; TG: Triglyceride; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ACET: Acupoint catgut embedding therapy.